Kanada - Englisch - Health Canada

otsuka pharmaceutical co ltd - aripiprazole - powder for suspension, sustained-release - 300mg - aripiprazole 300mg - atypical antipsychotics

Kanada - Englisch - Health Canada

otsuka pharmaceutical co ltd - aripiprazole - powder for suspension, sustained-release - 400mg - aripiprazole 400mg - atypical antipsychotics

Kanada - Englisch - Health Canada

otsuka pharmaceutical co ltd - aripiprazole - tablet - 2mg - aripiprazole 2mg - atypical antipsychotics

Kanada - Englisch - Health Canada

otsuka pharmaceutical co ltd - aripiprazole - tablet - 5mg - aripiprazole 5mg - atypical antipsychotics

Kanada - Englisch - Health Canada

otsuka pharmaceutical co ltd - aripiprazole - tablet - 10mg - aripiprazole 10mg - atypical antipsychotics

Kanada - Englisch - Health Canada

otsuka pharmaceutical co ltd - aripiprazole - tablet - 15mg - aripiprazole 15mg - atypical antipsychotics

Kanada - Englisch - Health Canada

otsuka pharmaceutical co ltd - aripiprazole - tablet - 30mg - aripiprazole 30mg - atypical antipsychotics

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

zydus pharmaceuticals usa inc. - aripiprazole (unii: 82vfr53i78) (aripiprazole - unii:82vfr53i78) - aripiprazole tablets are indicated for the treatment of - schizophrenia - irritability associated with autistic disorder - treatment of tourette's disorder aripiprazole is contraindicated in patients with a history of a hypersensitivity reaction to aripiprazole. reactions have ranged from pruritus/urticaria to anaphylaxis [see adverse reactions (6.2)]. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to atypical antipsychotics, including aripiprazole, during pregnancy. healthcare providers are encouraged to register patients by contacting the national pregnancy registry for atypical antipsychotics at 1-866-961-2388 or visit  http://womensmentalhealth.org/clinical-and-researchprograms/pregnancyregistry/. risk summary neonates exposed to antipsychotic drugs, including aripiprazole, during the third trimester of pregnancy are at risk for extrapyramidal and/or withdrawal symptoms following delivery (see clinical considerations) . overall availabl

Singapur - Englisch - HSA (Health Sciences Authority)

otsuka pharmaceuticals (singapore) pte. ltd. - aripiprazole - solution - aripiprazole 1.0 mg/ml

Singapur - Englisch - HSA (Health Sciences Authority)

otsuka pharmaceuticals (singapore) pte. ltd. - aripiprazole - tablet - aripiprazole 2mg